Segal Leopoldo N, Blaser Martin J
1 Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University Human Microbiome Program, New York University School of Medicine, New York, New York.
Ann Am Thorac Soc. 2014 Jan;11 Suppl 1(Suppl 1):S21-7. doi: 10.1513/AnnalsATS.201306-189MG.
The development of culture-independent techniques has revolutionized our understanding of how our human cells interact with the even greater number of microbial inhabitants of our bodies. As part of this revolution, data are increasingly challenging the old dogma that in health, the lung mucosa is sterile. To understand how the lung microbiome may play a role in human health, we identified five major questions for lung microbiome research: (1) Is the lung sterile? (2) Is there a unique core microbiome in the lung? (3) How dynamic are the microbial populations? (4) How do pulmonary immune responses affect microbiome composition? and (5) Are the lungs influenced by the intestinal immune responses to the gut microbiome? From birth, we are exposed to continuous microbial challenges that shape our microbiome. In our changing environment, perturbation of the gut microbiome affects both human health and disease. With widespread antibiotic use, the ancient microbes that formerly resided within us are being lost, for example, Helicobacter pylori in the stomach. Animal models show that antibiotic exposure in early life has developmental consequences. Considering the potential effects of this altered microbiome on pulmonary responses will be critical for future investigations.
不依赖培养技术的发展彻底改变了我们对人类细胞如何与体内数量更多的微生物群落相互作用的理解。作为这场变革的一部分,数据越来越多地挑战着旧有观念,即健康状态下肺黏膜是无菌的。为了理解肺部微生物群可能如何在人类健康中发挥作用,我们确定了肺部微生物群研究的五个主要问题:(1)肺部是无菌的吗?(2)肺部是否存在独特的核心微生物群?(3)微生物群落的动态变化如何?(4)肺部免疫反应如何影响微生物群组成?以及(5)肺部是否受到肠道对肠道微生物群免疫反应的影响?从出生起,我们就不断受到塑造我们微生物群的微生物挑战。在不断变化的环境中,肠道微生物群的扰动会影响人类健康和疾病。随着抗生素的广泛使用,以前存在于我们体内的古老微生物正在消失,例如胃中的幽门螺杆菌。动物模型表明,生命早期接触抗生素会产生发育后果。考虑到这种改变的微生物群对肺部反应的潜在影响对于未来的研究至关重要。